Redwood Memorial Hospital
3300 Renner Dr, Fortuna, CA · Providence · · NPI 1043292303
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $37.90 – $42.44 | 2 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $216.03 – $280.85 | 2 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.05 – $0.05 | 1 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.90 – $2.42 | 2 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $14.85 – $16.52 | 2 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $5.25 – $5.74 | 2 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $127.23 – $127.23 | 1 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $280.93 – $280.93 | 1 |
| Inj for ext venography CPT 36005 | $7,802.49 | $15,299.00 | $8,222.00 – $20,799.00 | 2 |
| Inj for mammo ductogram CPT 19030 | not published | not published | $8,222.00 – $20,799.00 | 2 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $2.26 – $3.46 | 2 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $878.52 – $1,212.71 | 2 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $4.85 – $4.85 | 1 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $6.64 – $86.08 | 2 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $34.50 – $34.50 | 1 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $6.81 – $19.03 | 2 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $86.08 – $86.08 | 1 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $316.00 – $316.00 | 1 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $10.58 – $19.09 | 2 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $177.72 – $234.38 | 2 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $4,400.52 – $5,541.14 | 2 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $3.70 – $4.35 | 2 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $2.79 – $2.79 | 1 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $275.60 – $275.60 | 1 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $8.71 – $9.92 | 2 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $149.73 – $174.94 | 2 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $16.19 – $16.19 | 1 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $0.56 – $6.01 | 2 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $125.95 – $134.21 | 2 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $151.95 – $152.36 | 2 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $154.98 – $161.05 | 2 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | not published | not published | $8,222.00 – $8,222.00 | 1 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $8,222.00 – $8,222.00 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $8,222.00 – $8,222.00 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $8,222.00 – $8,222.00 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $8,222.00 – $8,222.00 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.56 – $3.04 | 2 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $8.37 – $8.37 | 1 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $26.57 – $26.57 | 1 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $97.80 – $158.77 | 2 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $38.74 – $38.74 | 1 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $3.81 – $5.22 | 2 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $104.83 – $154.53 | 2 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.26 – $0.33 | 2 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $752.14 – $988.87 | 2 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $5,981.00 – $20,799.00 | 4 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $65.45 – $65.45 | 1 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $2.46 – $2.46 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $241.74 | $474.00 | $1,333.00 – $20,799.00 | 4 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $1,333.00 – $20,799.00 | 4 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $20.99 – $25.91 | 2 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $77.59 – $100.86 | 2 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $3.46 – $3.83 | 2 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $3.97 – $5.30 | 2 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $2.90 – $3.16 | 2 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $2.76 – $5.14 | 2 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $130.53 – $173.88 | 2 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $48.90 – $127.61 | 2 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $2.23 – $2.65 | 2 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $1.18 – $1.18 | 1 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $36.28 – $44.05 | 2 |
| Inj levocarnitine per 1 gm HCPCS J1955 | $182.65 | $358.13 | $48.58 – $61.29 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.07 – $2.23 | 2 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $14.19 – $19.09 | 2 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $10.27 – $12.95 | 2 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $84.15 | $165.00 | $0.11 – $0.11 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $12.68 – $36.40 | 2 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $501.28 – $658.21 | 2 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $38.01 – $38.01 | 1 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $4,880.36 – $4,880.36 | 1 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $1,847.00 – $1,847.00 | 1 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $101.43 – $101.43 | 1 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $5.39 – $5.39 | 1 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $216.06 – $661.26 | 2 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $818.23 – $818.23 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $1,257.44 – $1,575.58 | 2 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $230.51 – $230.51 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $84.15 | $165.00 | $7.65 – $24.00 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $4.15 – $6.14 | 2 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.79 – $2.79 | 1 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $2.79 – $3.25 | 2 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $16.97 – $16.97 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.72 – $2.57 | 2 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $55.04 – $96.55 | 2 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $326.41 – $496.99 | 2 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $40.97 – $50.44 | 2 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $15.74 – $17.42 | 2 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $15.52 – $19.76 | 2 |
| Inj multihance HCPCS A9577 | not published | not published | $3.49 – $9.43 | 2 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $3.42 – $9.92 | 2 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.83 – $2.01 | 2 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $6.81 – $6.81 | 1 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $907.77 – $1,371.81 | 2 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | not published | not published | $3,331.00 – $20,799.00 | 4 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $3.24 – $3.24 | 1 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $154.18 – $188.23 | 2 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $5,981.00 – $25,998.00 | 4 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $5,981.00 – $25,998.00 | 4 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $94.48 – $94.48 | 1 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,700.99 – $1,700.99 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.